Objective: To study the frequency of neurological disorders associated to HIV infection. Methods: This cross-sectional study was carried out from 16th June to 16th September 2014 and included all 289 HIV-outpatients admitted to the Parakou University hospital. All data were recorded, physical examination was performed and the medical sheet of each patient was assessed. The diagnosis of neurological disorder (central and peripheral) was based on clinical features, past medical history, biological test and CT-scan data after multidisciplinary staff. Epi-data and Epi-Info 6.04C were used to perform analysis. Results: They were 73 (25.3%) male with a mean age of 38.0 years +/−？10.1 years. The mean duration of disease was 48.5 months +/− 37.1 months. 150 (51.9%) of them were at Stage 3 of the disease. All patients (99.7%) were infected by HIV1, 188 (76.1%) had CD4 cells at the onset of the follow-up less than 350 cells/mm3 and 260 (90.0%) were on ART. Among the 289 patients, 110 had at least one neurological disorder, the frequency of neurological disorders was 38.1%. The main neurological disorders were peripheral neuropathy (34.3%), isolated headache (5.2%), stroke (0.7%), cerebral toxoplasmosis (0.7%) and one case of dementia (0.7%). The main associated factors were the age of patient and exposure on neurotoxic drug, especially ART. Conclusion: The neurological disorders were more frequent among HIV patients with a high frequency of peripheral neuropathy probably due to ART.
References
[1]
Rozenbaum, W. (2001) Guide de l’infection à VIH. Impact médecine, Paris.
[2]
Moulignier, A. (2007) Le complexe démentiel associé au VIH: Aspects particuliers chez les sujets agés. Psychologie et neuropsychiatrie du vieillissement, 5, 193-207.
[3]
ONUSIDA (2013) Rapport ONUSIDA sur l’épidémie mondiale de sida.
[4]
McArthur, J.C., Brew, B.J. and Nath, A. (2005) Neurological Complications of HIV Infection. The Lancet Neurology, 4, 543-555.
https://doi.org/10.1016/S1474-4422(05)70165-4
[5]
Adoukonou, T.A., Kouna-Ndouongo, P., Kpangon, A., Gnonlonfoun, D., Kpacha, B., Dovonou, A. and Houinato, D. (2017) Distal Sensory Polyneuropathy among HIV-Infected Patients at Parakou University Hospital, Benin, 2011. Médecine et Santé Tropicales, 27, 190-194. https://doi.org/10.1684/mst.2017.0685
[6]
Millogo, A., Ki-Zerbo, G.A., Sawadogo, A.B., Ouedraogo, I., Yameogo, A., Tamini, M.M., et al. (1999) Manifestations neurologiques associées à l’infection par le VIH au Centre hospitalier de Bobo-Dioulasso (Burkina Faso). Bulletin de la Société de Pathologie Exotique, 92, 23-26.
[7]
Mohraz, M., Bayat, Z., Behtaj, M., Shooka, E., Seyedalinaghi, S., Jabbari, H., et al. (2014) Neurological Manifestations in HIV Positive Patients in Tehran, Iran. Asian Pacific Journal of Tropical Disease, 4, S481-S485.
https://doi.org/10.1016/S2222-1808(14)60494-1
[8]
Chen, H., Cliffordb, D.B., Deng, L.J., Wu, K.L., Lee, A.J., Bosch, R.J., et al. (2013) Peripheral Neuropathy in ART-Experienced Patients: Prevalence and Risk Factors. Journal of NeuroVirology, 19, 557-564. https://doi.org/10.1007/s13365-013-0216-4
[9]
Evans, S.R., Ellis, R.J., Chen, H., Yeh, T., Lee, A.J., Schifitto, G., et al. (2011) Peripheral Neuropathy in HIV: Prevalence and Risk Factors. AIDS, 25, 919-928.
https://doi.org/10.1097/QAD.0b013e328345889d
[10]
Wateba, M.I., Fiogbe, A., Assogba, K. and Tidjani, O. (2013) Prévalence des neuropathies périphériques (NP) et leurs facteurs associés chez les patients sous traitement antirétroviral suivis dans le service des Maladies infectieuses du CHU sylvanus olympio de Lomé. Cames Sante, 1, 24-27.
[11]
Benjamin, L.A., Bryer, A., Emsley, H.C.A., Khoo, S., Solomon, T. and Connor, M.D. (2012) HIV Infection and Stroke: Current Perspectives and Future Directions. The Lancet Neurology, 11, 878-890. https://doi.org/10.1016/S1474-4422(12)70205-3
[12]
De Broucker, T. (2013) Complications neurologiques par le virus de l’immuno-déficience humaine (VIH). Pratique Neurologique—FMC, 4, 213-228.
https://doi.org/10.1016/j.praneu.2013.10.002
